Insmed (INSM) Total Debt (2012 - 2026)
Insmed (INSM) posted quarterly Total Debt of $546.8 million for Q1 2026, down 50.52% year-over-year from $1.1 billion in Q1 2025, and up 1.07% quarter-over-quarter from $541.0 million in Q4 2025.
Insmed (INSM) Total Debt (2012 - 2026) Analysis & Trends
Insmed's Total Debt history runs 15 years deep, the most recent figure standing at $546.8 million for Q1 2026.
- In Q1 2026, Total Debt fell 50.52% year-over-year to $546.8 million; the TTM figure through Mar 2026 stood at $546.8 million (down 50.52% YoY), while the FY2025 annual figure was $541.0 million, down 50.97% from the prior year.
- Total Debt for Q1 2026 stood at $546.8 million, up from $541.0 million in the prior quarter.
- The five-year high for Total Debt was $1.2 billion in Q3 2023, with the low at $538.5 million in Q2 2025.
- The 5-year median for Total Debt is $1.1 billion (2024), against an average of $930.3 million.
- The sharpest annual moves came in 2022 and 2025: Total Debt jumped 121.25% in 2022, then slumped 54.02% in 2025.
- Insmed's Total Debt stood at $1.1 billion in 2022, then advanced by 2.67% to $1.2 billion in 2023, then slipped by 4.49% to $1.1 billion in 2024, then sank by 50.97% to $541.0 million in 2025, then gained by 1.07% to $546.8 million in 2026.
- Business Quant data shows INSM's Total Debt at $546.8 million in Q1 2026, $541.0 million in Q4 2025, and $539.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 546.77 Mn |
| Mar 31, 2026 | 546.77 Mn |
| Dec 31, 2025 | 540.96 Mn |
| Sep 30, 2025 | 539.72 Mn |
| Jun 30, 2025 | 538.51 Mn |
| Mar 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 971.76 Mn |
| Jun 30, 2024 | 1.17 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.17 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 784.80 Mn |
| Jun 30, 2022 | 800.00 Mn |
| Mar 31, 2022 | 800.00 Mn |
| Dec 31, 2021 | 566.59 Mn |
| Sep 30, 2021 | 557.60 Mn |